questionsmedicales.fr
Hormones gonadiques
Hormones sexuelles stéroïdiennes
Congénères de la progestérone
Progestérone
Hydroxyprogestérones
Hydroxyprogestérones : Questions médicales fréquentes
Diagnostic
5
Déséquilibre hormonal
Bilan hormonal
Progestérone
Tests sanguins
Irrégularités menstruelles
Ménopause
Consultation médicale
Saignements anormaux
Échographie
Anomalies utérines
Symptômes
5
Excès hormonal
Changements d'humeur
Effets secondaires
Maux de tête
Ménopause
Bouffées de chaleur
Fluctuations d'humeur
Traitements hormonaux
Prévention
5
Mode de vie sain
Consultation médicale
Examens réguliers
Déséquilibres hormonaux
Alimentation
Régulation hormonale
Stress
Équilibre hormonal
Exercice physique
Santé générale
Traitements
5
Administration
Voie orale
Traitements combinés
Hormones
Complications
5
Caillots sanguins
Cancers
Cancer du sein
Utilisation prolongée
Effets secondaires
Consultation médicale
Grossesse
Surveillance médicale
Réaction allergique
Démangeaisons
Facteurs de risque
5
Obésité
Antécédents familiaux
Antécédents médicaux
Cancers
Traitements hormonaux
Déséquilibre
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hydroxyprogestérones : Questions médicales les plus fréquentes",
"headline": "Hydroxyprogestérones : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hydroxyprogestérones : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-29",
"dateModified": "2026-07-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hydroxyprogestérones"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Progestérone",
"url": "https://questionsmedicales.fr/mesh/D011374",
"about": {
"@type": "MedicalCondition",
"name": "Progestérone",
"code": {
"@type": "MedicalCode",
"code": "D011374",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D06.472.334.851.687.750"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "17alpha-Hydroxyprogestérone",
"alternateName": "17-alpha-Hydroxyprogesterone",
"url": "https://questionsmedicales.fr/mesh/D019326",
"about": {
"@type": "MedicalCondition",
"name": "17alpha-Hydroxyprogestérone",
"code": {
"@type": "MedicalCode",
"code": "D019326",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D06.472.334.851.687.750.478.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Caproate d'hydroxyprogestérone",
"alternateName": "17 alpha-Hydroxyprogesterone Caproate",
"url": "https://questionsmedicales.fr/mesh/D000077713",
"about": {
"@type": "MedicalCondition",
"name": "Caproate d'hydroxyprogestérone",
"code": {
"@type": "MedicalCode",
"code": "D000077713",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D06.472.334.851.687.750.478.400.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prégnanetriol",
"alternateName": "Pregnanetriol",
"url": "https://questionsmedicales.fr/mesh/D011279",
"about": {
"@type": "MedicalCondition",
"name": "Prégnanetriol",
"code": {
"@type": "MedicalCode",
"code": "D011279",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D06.472.334.851.687.750.478.400.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hydroxyprogestérones",
"alternateName": "Hydroxyprogesterones",
"code": {
"@type": "MedicalCode",
"code": "D006908",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ranjith Ramasamy",
"url": "https://questionsmedicales.fr/author/Ranjith%20Ramasamy",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, University of Miami Miller School of Medicine, Miami, Florida."
}
},
{
"@type": "Person",
"name": "Raman Venkataramanan",
"url": "https://questionsmedicales.fr/author/Raman%20Venkataramanan",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA."
}
},
{
"@type": "Person",
"name": "Steve N Caritis",
"url": "https://questionsmedicales.fr/author/Steve%20N%20Caritis",
"affiliation": {
"@type": "Organization",
"name": "Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, UPMC Magee-Women's Hospital, Pittsburgh, Pennsylvania."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": "Society for Maternal-Fetal Medicine, Washington, DC."
}
},
{
"@type": "Person",
"name": "Christine K Wagner",
"url": "https://questionsmedicales.fr/author/Christine%20K%20Wagner",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, University of Albany, Albany, NY, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A novel MAMLD1 variant in a newborn with hypospadias and elevated 17-hydroxyprogesterone.",
"datePublished": "2023-11-24",
"url": "https://questionsmedicales.fr/article/37996649",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s42000-023-00513-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study on 20-hydroxyprogesterone: Chiral resolution, Content determination and Progesterone-like activity.",
"datePublished": "2024-07-23",
"url": "https://questionsmedicales.fr/article/39053703",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jsbmb.2024.106592"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigating the potential neuroprotective benefits of taurine and Dihydrotestosterone and Hydroxyprogesterone levels in SH-SY5Y cells.",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38867846",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnagi.2024.1379431"
}
},
{
"@type": "ScholarlyArticle",
"name": "Solubility, Thermodynamic Parameters, and Dissolution Properties of 17-α Hydroxyprogesterone in 13 Pure Solvents.",
"datePublished": "2024-03-31",
"url": "https://questionsmedicales.fr/article/38617637",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsomega.3c09922"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Novel A105Y Mutant of CYP17A1 Exhibits Almost Perfect Regioselectivity in the Production of 17α-Hydroxyprogesterone.",
"datePublished": "2024-10-23",
"url": "https://questionsmedicales.fr/article/39440611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jafc.4c05982"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Hormones gonadiques",
"item": "https://questionsmedicales.fr/mesh/D042341"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hormones sexuelles stéroïdiennes",
"item": "https://questionsmedicales.fr/mesh/D012739"
},
{
"@type": "ListItem",
"position": 4,
"name": "Congénères de la progestérone",
"item": "https://questionsmedicales.fr/mesh/D045167"
},
{
"@type": "ListItem",
"position": 5,
"name": "Progestérone",
"item": "https://questionsmedicales.fr/mesh/D011374"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hydroxyprogestérones",
"item": "https://questionsmedicales.fr/mesh/D006908"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hydroxyprogestérones - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hydroxyprogestérones",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-26",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hydroxyprogestérones",
"description": "Comment diagnostiquer un déséquilibre hormonal ?\nQuels tests sont utilisés pour évaluer les progestérones ?\nQuels symptômes indiquent un besoin d'hydroxyprogestérones ?\nQuand consulter un médecin pour des problèmes hormonaux ?\nLes échographies sont-elles utiles dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006908#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hydroxyprogestérones",
"description": "Quels sont les symptômes d'un faible taux de progestérone ?\nComment reconnaître un excès de progestérone ?\nLes hydroxyprogestérones peuvent-elles causer des effets secondaires ?\nQuels symptômes sont liés à la ménopause ?\nLes changements d'humeur sont-ils fréquents avec ces traitements ?",
"url": "https://questionsmedicales.fr/mesh/D006908#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hydroxyprogestérones",
"description": "Comment prévenir les déséquilibres hormonaux ?\nLes examens réguliers aident-ils à prévenir des problèmes hormonaux ?\nL'alimentation influence-t-elle les niveaux hormonaux ?\nLe stress peut-il affecter les hormones ?\nLes exercices physiques aident-ils à réguler les hormones ?",
"url": "https://questionsmedicales.fr/mesh/D006908#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hydroxyprogestérones",
"description": "Comment les hydroxyprogestérones sont-elles administrées ?\nQuels troubles sont traités par les hydroxyprogestérones ?\nLes hydroxyprogestérones sont-elles sûres à long terme ?\nPeut-on combiner hydroxyprogestérones avec d'autres traitements ?\nQuel est le rôle des hydroxyprogestérones dans la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D006908#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hydroxyprogestérones",
"description": "Quelles complications peuvent survenir avec les hydroxyprogestérones ?\nLes hydroxyprogestérones augmentent-elles le risque de cancer ?\nComment gérer les effets secondaires graves ?\nLes femmes enceintes doivent-elles éviter les hydroxyprogestérones ?\nQuels signes indiquent une réaction allergique ?",
"url": "https://questionsmedicales.fr/mesh/D006908#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hydroxyprogestérones",
"description": "Quels facteurs augmentent le risque de déséquilibre hormonal ?\nL'âge influence-t-il le risque de troubles hormonaux ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe mode de vie peut-il affecter les niveaux hormonaux ?\nLes traitements hormonaux antérieurs influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006908#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un déséquilibre hormonal ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un bilan hormonal sanguin permet d'évaluer les niveaux d'hormones, y compris les progestérones."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les progestérones ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins mesurent les niveaux de progestérone et d'autres hormones sexuelles."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin d'hydroxyprogestérones ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des irrégularités menstruelles, des saignements anormaux ou des symptômes de ménopause."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des problèmes hormonaux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si vous avez des cycles irréguliers, des douleurs ou des saignements inhabituels."
}
},
{
"@type": "Question",
"name": "Les échographies sont-elles utiles dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles aident à visualiser les anomalies utérines pouvant affecter les hormones."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un faible taux de progestérone ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cycles menstruels irréguliers, saignements entre les règles, fatigue et irritabilité."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un excès de progestérone ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes incluent prise de poids, fatigue, et changements d'humeur."
}
},
{
"@type": "Question",
"name": "Les hydroxyprogestérones peuvent-elles causer des effets secondaires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets comme des maux de tête, des nausées ou des changements d'appétit."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à la ménopause ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bouffées de chaleur, sécheresse vaginale, et troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Les changements d'humeur sont-ils fréquents avec ces traitements ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des fluctuations d'humeur peuvent survenir lors de l'utilisation d'hydroxyprogestérones."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déséquilibres hormonaux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, gérer le stress et consulter régulièrement un médecin."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à prévenir des problèmes hormonaux ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers permettent de détecter précocement des déséquilibres."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les niveaux hormonaux ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut aider à réguler les niveaux d'hormones."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter les hormones ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber l'équilibre hormonal et provoquer des symptômes."
}
},
{
"@type": "Question",
"name": "Les exercices physiques aident-ils à réguler les hormones ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer l'équilibre hormonal et la santé générale."
}
},
{
"@type": "Question",
"name": "Comment les hydroxyprogestérones sont-elles administrées ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être prises par voie orale, injectable ou sous forme de crème."
}
},
{
"@type": "Question",
"name": "Quels troubles sont traités par les hydroxyprogestérones ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées pour traiter l'aménorrhée, les saignements anormaux et l'infertilité."
}
},
{
"@type": "Question",
"name": "Les hydroxyprogestérones sont-elles sûres à long terme ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont généralement sûres, mais un suivi médical est recommandé pour éviter les risques."
}
},
{
"@type": "Question",
"name": "Peut-on combiner hydroxyprogestérones avec d'autres traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être combinées avec d'autres hormones ou traitements selon les besoins."
}
},
{
"@type": "Question",
"name": "Quel est le rôle des hydroxyprogestérones dans la grossesse ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles soutiennent la grossesse en maintenant l'endomètre et en réduisant les contractions."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les hydroxyprogestérones ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des caillots sanguins, des troubles hépatiques ou des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les hydroxyprogestérones augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un risque accru de cancer du sein avec une utilisation prolongée."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires graves ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez immédiatement un médecin si vous ressentez des effets secondaires graves."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter les hydroxyprogestérones ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles doivent être utilisées avec précaution et sous surveillance médicale pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une réaction allergique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou des difficultés respiratoires peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de déséquilibre hormonal ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le stress, et des antécédents familiaux de troubles hormonaux sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de troubles hormonaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout pendant la périménopause et la ménopause."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles hormonaux ou de cancers peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter les niveaux hormonaux ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme, l'alcool et une mauvaise alimentation peuvent perturber l'équilibre hormonal."
}
},
{
"@type": "Question",
"name": "Les traitements hormonaux antérieurs influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements hormonaux antérieurs peuvent affecter les niveaux et le risque de déséquilibre."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/07/2026
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Urology, University of Miami Miller School of Medicine, Miami, Florida.
Publications dans "Hydroxyprogestérones" :
5 publications dans cette catégorie
Affiliations :
Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.
Magee-Women's Research Institute, Pittsburgh, PA, USA.
Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Publications dans "Hydroxyprogestérones" :
4 publications dans cette catégorie
Affiliations :
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, UPMC Magee-Women's Hospital, Pittsburgh, Pennsylvania.
Publications dans "Hydroxyprogestérones" :
4 publications dans cette catégorie
Affiliations :
Society for Maternal-Fetal Medicine, Washington, DC.
Publications dans "Hydroxyprogestérones" :
4 publications dans cette catégorie
Affiliations :
Department of Psychology, University of Albany, Albany, NY, USA.
Publications dans "Hydroxyprogestérones" :
4 publications dans cette catégorie
Affiliations :
Department of Integrative Anatomical Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Department of Urology, University of Miami Miller School of Medicine, Miami, Florida.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Department of Urology, University of Manitoba, Winnipeg, Manitoba, Canada.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Department of Urology, University of Miami Miller School of Medicine, Miami, Florida.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, National Engineering Laboratory for Industrial Enzymes, Tianjin University of Science and Technology, Tianjin 300457, P. R. China.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Key Laboratory of Industrial Fermentation Microbiology of the Ministry of Education, Tianjin Key Laboratory of Industrial Microbiology, College of Biotechnology, National Engineering Laboratory for Industrial Enzymes, Tianjin University of Science and Technology, Tianjin 300457, P. R. China.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Department of Medicine IV, 74939 University Hospital, LMU Munich , Munich, Germany.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Department of Medicine IV, 74939 University Hospital, LMU Munich , Munich, Germany.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, Department of Pharmacology and Experimental Therapeutics, Division of Maternal Fetal Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
University of Zambia School of Medicine.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Publications dans "Hydroxyprogestérones" :
3 publications dans cette catégorie
Affiliations :
University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Publications dans "Hydroxyprogestérones" :
Disorders of sex development (DSD) have complex pathogenesis, and evidence suggests an association between MAMLD1 defects and DSD. MAMLD1 is expressed in gonadal tissues and affected males exhibit hyp...
Genetic testing of the proband and parents was conducted using whole-exome and Sanger sequencing. The identified variant was transfected into HEK293T cells to assess mutant protein expression using we...
A novel heterozygous variant was identified in the proband's MAMLD1, NM_005491.5: c.1619_1637del (p.Gln540Alafs*72), inherited from the mother. In transfected cells, the wild-type and mutant proteins ...
Severe hypospadias in the proband may be attributed to a novel MAMLD1 variant, whereas the 17α-OH elevation might be related to interference with CYP17A1 transcriptional activation. This study expands...
20-hydroxyprogesterone (20-DHP) is a natural metabolite of progesterone which occurs with two diastereoisomers: 20α-DHP and 20β-DHP. They have drawn attention for their progesterone-like activity sinc...
Taurine, an amino acid abundantly found in the brain and other tissues, has potential neuroprotective properties. Alzheimer's disease (AD) is a commonly occurring type of dementia, which becomes more ...
The effects of various taurine concentrations (0.25, and 0.75 mg/mL), and LPS (0.1, and 12 mg/mL) on the SH-SY5Y cell line were assessed using the MTT assay. The levels of DHT and DHP were quantified ...
The results of the MTT assay showed that treatment with taurine at concentrations of 0.25, and 0.75 mg/mL reduces the toxicity of LPS in SH-SY5Y cells. ELISA results indicated that taurine at a concen...
Our study findings revealed that the expression of miRNA-181 and miRNA-21 can be enhanced by taurine. Consequently, exploring the targeting of taurine, miRNA-181, and miRNA-21 or considering hormone t...
The static gravimetric method was used to measure the solubility of 17-α hydroxyprogesterone (OHP) in 13 pure solvents ranging from 278.15 to 323.15 K. The results indicate that the experimental solub...
17α-Hydroxyprogesterone (17α-OHP) is a steroid hormone with significant biological activity that can be obtained by catalyzing progesterone (PROG), the main product of sitosterol, through CYP17A1. How...
Makena (17-hydroxyprogesterone caproate) was FDA approved for prevention of recurrent spontaneous preterm birth in 2011 under the accelerated approval pathway but fundamental pharmacokinetic or pharma...
The purpose of this study was to evaluate the dosing regimen for 17-hydroxyprogesterone by analyzing three data sets that evaluated 17-hydroxyprogesterone caproate pharmacology: the Maternal-Fetal Med...
Data from the Omega 3 study were utilized to determine if plasma concentration was related to spontaneous preterm birth risk and if a threshold concentration could be identified. Data from the Obstetr...
Analysis of the Omega 3 dataset indicated that the risk of spontaneous preterm birth decreased as the log of 17-hydroxyprogesterone caproate increased [odds ratio (95%CI) 0.04 (0.00 - 0.90)]. A steady...
The dosing regimen for 17-hydoxyprogesterone caproate was inadequate. There is a significant inverse relationship between drug concentration and spontaneous preterm birth. Risk is lowest when concentr...
The most suitable biochemical markers for therapy adjustment in patients with congenital adrenal hyperplasia are controversial. 11-Oxygenated androgens are a promising new approach. The objective of t...
Fifty-one samples of steroid day-profiles from 17 patients were additionally analysed for 11-ketotestosterone, retrospectively. All patients were treated in our university outpatient clinic for paedia...
Both steroids show a circadian diurnal rhythm. 17-hydroxyprogesterone and 11-ketotestosterone correlate significantly. 11-Ketotestosterone showed a positive correlation with BMI at all times of the da...
11-Ketotestosterone shows circadian rhythmicity in our cohort and correlates with 17-hydroxyprogesterone. These findings serve as an important basis for prospective research into 11-oxygenated androge...
Spontaneous preterm birth significantly increases the risk for a recurrent preterm birth. Only a few identifiable clinical risk factors can be referenced in counseling for recurrent preterm birth. Fur...
This study aimed to determine if histologic patterns are associated with recurrent preterm birth among patients with an index spontaneous preterm birth. A secondary objective was to determine if place...
This was a retrospective cohort study at a single institution of women with singleton pregnancies with an index spontaneous preterm birth and a subsequent birth within the same hospital system between...
A total of 352 patients were included. Acute inflammation was the most common histologic type seen among patients with spontaneous preterm birth (44.1%), followed by chronic inflammation (40.9%) and m...
Although acute inflammation was prevalent among spontaneous preterm births, more than half of the spontaneous preterm births were not associated with acute inflammation. Low-grade acute inflammation w...
The synthetic progestin, 17α-hydroxyprogesterone caproate (17-OHPC), is administered to pregnant individuals at risk for preterm birth and is likely transferred from mother to fetus. Yet, there is lit...
17α-Hydroxyprogesterone (17α-OH-PROG) is an important intermediate with a wide range of applications in the pharmaceutical industry. Strategies based on efficient electron transfer and cofactor regene...